Alcor Scientific Advisory Board

Antonei B. Csoka, Ph.D.

Postdoctoral Associate
Department of Molecular and Cellular Biology
Roswell Park Cancer Institute, Buffalo, New York

Dr. Csoka received his B.S. in Genetics from the University of Newcastle, U.K. in 1991, his M.S. in Molecular Pathology and Toxicology from the University of Leicester, U.K. in 1993, and his Ph.D. in Cell and Molecular Biology from the University of Debrecen, Hungary in 1998. He performed postdoctoral research at the University of California, San Francisco, where he cloned the human hyaluronidase genes, which are involved in fertilization, embryonic development, and cancer. As a postdoctoral research associate at Brown University from 2001 to 2003, Dr. Csoka was a key player in the identification of the gene that causes Hutchinson-Gilford Progeria Syndrome (progeria), a disease with many features of “accelerated aging.” It is hoped that the identification of the gene for progeria will provide insights into the mechanisms of normal aging. As a postdoctoral associate at Roswell Park Cancer Institute, Dr. Csoka is developing animal models of progeria, studying the role of nuclear lamina dysfunction in human aging, and investigating the potential of stem cells and cellular reprogramming for the treatment of age-related diseases.

Aubrey de Grey, Ph.D.
Chairman and Chief Science Officer, Methuselah Foundation
http://www.sens.org/

Aubrey de Grey received his BA, MA and PhD degrees from the University of Cambridge, Cambridge, UK, where he was formerly a research associate. He is currently chairman and chief science officer of the Methuselah Foundation and editor-in-chief of the academic journal Rejuvenation Research. His main research areas are the role and etiology of oxidative damage in mammalian aging, including both mitochondrial and extracellular free radical production and damage, and the design of interventions to reverse the age-related accumulation of oxidative and other damage. He is author of the book Ending Aging (2007) and subject of the British Channel 4 documentary Do You Want to Live Forever? (2007).

Robert A. Freitas, JD
Senior Research Fellow, Institute for Molecular Manufacturing
http://www.rfreitas.com/

Robert A. Freitas Jr., J.D., published the first detailed technical design study of a medical nanorobot ever published in a peer-reviewed mainstream biomedical journal and is the author of Nanomedicine, the first book-length technical discussion of the medical applications of nanotechnology and medical nanorobotics. Volume I was published in October 1999 by Landes Bioscience while Freitas was a Research Fellow at the Institute for Molecular Manufacturing (IMM) in Palo Alto, California. Freitas published Volume IIA in October 2003 while serving as a Research Scientist at Zyvex Corp., a nanotechnology company headquartered in Richardson, TX during 2000-2004. Freitas is now completing Volumes IIB and III and consulting on molecular assembler design as Senior Research Fellow at IMM.

Bart Kosko, Ph.D.
Professor of Electrical Engineering
http://sipi.usc.edu/~kosko/

Dr. Kosko received his bachelors degrees in Economics and Philosophy from the University of Southern California, the masters degree in Applied Mathematics from the University of California, San Diego, and the Ph.D. degree in Electrical Engineering from the University of California, Irvine. His research interests include Adaptive Systems, Fuzzy Theory, Neural Networks, Dynamical Systems, Nonlinear Signal Processing, Intelligent Agents, Smart Materials, and Stochastic Resonance.

He has written seven books, including: Heaven in a Chip, Random House, 2000, Nanotime, Avon Books, 1997, Fuzzy Engineering, Prentice Hall, 1996, Fuzzy Thinking, Hyperion/Disney Books, 1993, Neural Networks for Signal Processing (editor), Prentice-Hall, 1991, and Neural Networks and Fuzzy Systems, Prentice-Hall, 1991 (ISBN 0-13-611435-0). He has published over one hundred technical papers.

Dr. Kosko's technical activities include: Advisory Board: IEEE Transactions on Fuzzy Systems, Associate Editor: Information Sciences, Associate Editor: Neural Networks, Associate Editor: Soft Computing Research Journal, Governing Board, International Neural Network Society, Managing Editor, Lecture Notes in Neural Computing (Springer-Verlag monograph series), Co-editor of November 1998 IEEE Proceedings special issue on Intelligent Signal Processing, Program Chairman, 1987 IEEE International Conference on Neural Networks (ICNN-87), Program and Organizing Chairman, ICNN-88, Program Co-Chairman, 1990 International Joint Conference on Neural Networks (IJCNN-90), Program Co-Chairman, 1990 International Fuzzy-Neural Conference (Iizuka-90), Program Co-Chairman, Iizuka-92, Program Co-Chairman, INNS WCNN-93, Program Co-Chairman, INNS WCNN-96, and a former Director of USC’s Signal and Image Processing Institute.

James B. Lewis, Ph.D.
http://www.halcyon.com/nanojbl/welcome.html


Dr. Lewis earned his B.A. degree in Chemistry in1967 from the University of Pennsylvania, Philadelphia, PA., his M.A. in Chemistry, 1968, Harvard University, Cambridge, MA., and his Ph.D.in Chemistry, 1972, Harvard University, Cambridge, MA. After his graduate work in RNA biochemistry and structure, Dr. Lewis spent 17 years studying the molecular biology of DNA tumor viruses, with emphasis on the adenovirus oncogenes.

He switched research focus upon joining Bristol-Myers Squibb, first doing some work on HIV proteins, and then spending 6 years working on active immunotherapy for cancer (cancer vaccines). During his last six months at BMS, he switched projects again, returning to molecular virology to begin a project to identify viral protein - cellular protein interactions that are important for the pathogenicity of HIV in the hope that these interactions would prove useful targets for drug screening. He has over 46 research papers published.

Over the past 10 years he has become increasingly interested in the evolution of current technology towards molecular nanotechnology, the anticipated ability to inexpensively fabricate complex molecular machinery having a broad range of capabilities. In his spare time he familiarized himself with the technological and scientific issues at a general level and co-edited two books on the subject: Nanotechnology: Research and Perspectives, BC Crandall and J. Lewis (editors), 1992, The MIT Press, Cambridge, Massachusetts and London, England, and Prospects in Nanotechnology: Toward Molecular Manufacturing. M. Krummenacker and J. Lewis (editors). 1995. John Wiley & Sons, Inc. New York, Chichester, Brisbane, Toronto, Singapore.

Ralph C. Merkle, Ph.D.
Director, Alcor Foundation
Director, Foresight Institute
http://www.merkle.com/

Dr. Merkle received his B.A. in Computer Science, U.C. Berkeley, 1974, his M.S. Computer Science, U.C. Berkeley, 1977, and his Ph.D., Electrical Engineering, Stanford, 1979. Thesis: Secrecy, authentication, and public key systems.

His current research interest is molecular manufacturing (also called nanotechnology). The central objective of molecular manufacturing is the design, modeling, and manufacture of systems that can inexpensively fabricate most products that can be specified in atomic detail.

This would include, for example, molecular logic elements connected in complex patterns to form molecular computers, molecular robotic arms or Stewart platforms (e.g., positional devices) able to position individual atoms or clusters of atoms under programmatic control (useful if we wish to make molecular computers and other molecular manufacturing systems), and a wide range of other molecular devices.

Dr. Merkle is an executive editor of the journal Nanotechnology, (published by IOPP) which publishes a broad range of articles both on molecular manufacturing and nano-scale research in general. He is a former Director of the Foresight Institute and chaired both the Fourth and Fifth Foresight Conferences on Molecular Nanotechnology, and a member of ACM, ACS, APS, and IEEE. He is also a Director of the Alcor Life Extension Foundation.

Further interests include cryonics, medical applications of nanotechnology, computational chemistry, reversible computing, neuroscience, extropians, and other areas. He is also interested in cryptography (including one-way hash functions and digital signatures based on one-way hash functions).

Dr. Merkle co-invented public key cryptography and received the Kanellakis Award. He has published 46 papers and holds 8 patents.

Marvin Minsky, Ph.D.
MIT Media Lab and MIT AI Lab
Toshiba Professor of Media Arts and Sciences
Professor of E.E. and C.S., M.I.T.  

http://web.media.mit.edu/~minsky/

Marvin Minsky has made many contributions to AI, cognitive psychology, mathematics, computational linguistics, robotics, and optics. In recent years he has worked chiefly on imparting to machines the human capacity for common-sense reasoning. His conception of human intellectual structure and function is presented in The Society of Mind (1987), which is also the title of the course he teaches at MIT.

 

He received the B.A. and Ph.D. in mathematics at Harvard and Princeton. In 1951 he built the SNARC, the first neural network simulator. His other inventions include mechanical hands and other robotic devices, the confocal scanning microscope, the "Muse" synthesizer for musical variations (with E. Fredkin), and the first LOGO "turtle" (with S. Papert).

 

A member of the NAS, NAE and Argentine NAS, he has received the ACM Turing Award, the MIT Killian Award, the Japan Prize, the IJCAI Research Excellence Award, and the Rank Prize.

 

Among Dr. Minsky's publications are Afterword to True Names, Alien Intelligence, Alienable Rights, Causal Diversity, Inventing the Confocal Microscope, Jokes and Cognition, Matter, Mind and Models, Music, Mind, and Meaning, Music Interview with Otto Laske, Negative Expertise, Perceptrons : Introduction to Computational Geometry, Semantic Information Processing, The Turing Option, More Turing Option chapters, Why People Think Computers Can't, and Will Robots Inherit the Earth.

Martine Rothblatt, Ph.D.
Chairman & Chief Executive Officer, United Therapeutics

Dr. Rothblatt received a B.A. degree from the University of California in 1977, her M.B.A and Juris Doctor from UCLA Schools of Management and Law in 1981, and her Ph.D. in Medical Ethics from the Royal College of Medicine and Dentistry, Queen Mary College, University of London in 2001. She has extensive experience in information technology development and pharmaceuticals. During 1982 -1995 she held at various times positions as President of Orbital Projects, Inc., President & CEO of Geostar Corporation, Chief Operating Officer of WorldSpace Corporation, and Chairman & CEO of Sirius Satellite Radio. From 1996 to the present she has been the Chairman & CEO of United Therapeutics Corporation of Silver Spring, MD, where she initiates and manages programs in cardiopulmonary medicine, virology and neuroscience. Her most recent book, Your Life or Mine:  How Geoethics Resolves the Conflicts Between Public and Private Interests in Xenotransplantation, was published by Ashgate House in 2004.

Michael D. West, Ph.D.
President & Chief Executive Officer Advanced Cell Technology

Dr. West received a B.S. degree from Rensselaer Polytechnic Institute in 1976, his M.S. in Biology from Andrews University in 1982, and his Ph.D. from Baylor College of Medicine in 1989. He has extensive academic and business experience in age-related degenerative disease, telomerase molecular biology, and human embryonic stem cells. From 1998-1999 he was a Co-founder and Chairman of Origen Therapeutics of South San Francisco, California, a company developing transgenic technology in commercial poultry. From 1990 to 1998 he was the founder, director and Vice President of Geron Corporation of Menlo Park, California, where he initiated and managed programs in telomerase diagnostics, telomerase inhibition, telomerase-mediated therapy, and human embryonic stem cells.